Impact of using Low Dose versus High Dose Antithymocyte Globulin Based Conditioning Regimen on the Outcome of Peripheral Blood Stem Cell Transplantation in Children with βeta-thalassemia Major

Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only commonly available curative treatment for people with thalassemia major (TM).This work aimed to study the impact of using low dose versus high dose anti thymocyte globulin (ATG (based conditioning regimen on the result...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Advances in Medicine and Medical Research 2022-04, p.33-41
Hauptverfasser: Shamhout, Hend M., Ahmed, Amira Y., Fathy, Gamal A., Badraia, Ibrahim M., Shebl, Shebl Saeed
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 41
container_issue
container_start_page 33
container_title Journal of Advances in Medicine and Medical Research
container_volume
creator Shamhout, Hend M.
Ahmed, Amira Y.
Fathy, Gamal A.
Badraia, Ibrahim M.
Shebl, Shebl Saeed
description Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only commonly available curative treatment for people with thalassemia major (TM).This work aimed to study the impact of using low dose versus high dose anti thymocyte globulin (ATG (based conditioning regimen on the results of peripheral blood stem cell transplantation in children with βeta- TM. Methods: This comparative study was established on 40 patients with βeta-thalassemia major (Pesaro class II and/or III) who subjected to (HSCT)   from donor who is related. Our patients received the same myeloablative regimen. They were then categorized according to dose of ATG into two groups: group I (Busulfan/Cyclophosphamide/Low dose ATG-30 mg) and group II (Busulfan/Cyclophosphamide/High dose ATG-110 mg). Results: There was no association between both groups according to the clinical features, transplant related complications in both groups. There was a higher risk of mucositis and infections in high dose group. (P = 0.024 & P = 0.046; respectively). Patients in low dose group achieved faster neutrophil engraftment with median value of (14 days). No difference was found in the incidence of post-transplant viral reactivation, graft versus host disease in both groups. Conclusions: Pesaro II, III thalassemia patients can safely receive hematopoietic stem cell transplantation (HSCT) with low dose ATG-30 mg regimen and attain the same result.
doi_str_mv 10.9734/jammr/2022/v34i1231371
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_9734_jammr_2022_v34i1231371</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_9734_jammr_2022_v34i1231371</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_9734_jammr_2022_v34i12313713</originalsourceid><addsrcrecordid>eNqdkEtOw0AMhkcIJCroFZAvUJoXbbOk4VEkEAi6j9zETaaaGUczk1a9FjfoBTgTCbDompUt6_f3S58QV2FwnU7jZLxBre04CqJovI0TGUZxGE_DEzGIkpvJaDZL09Oj_VwMnZOrIEmmSdxFB-LwpBssPPAaWidNBc-8gzt2BFuyrnWwkFX9e7g1Xvp6r7nYe4JHxatWSQNzdFRCxqaUXrLpGe9USU0G2ICvCV5bX7CmvuONrGxqsqhgrphL-PCkISOlYGnRuEah8dhzoENntVSl7UC7rhi-PsnjyNeo0DnSEuEFN2wvxdkalaPh37wQk4f7ZbYYFZads7TOGys12n0eBnnvLP9xlvfO8iNn8b8fvwFY_X5u</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Impact of using Low Dose versus High Dose Antithymocyte Globulin Based Conditioning Regimen on the Outcome of Peripheral Blood Stem Cell Transplantation in Children with βeta-thalassemia Major</title><source>Alma/SFX Local Collection</source><creator>Shamhout, Hend M. ; Ahmed, Amira Y. ; Fathy, Gamal A. ; Badraia, Ibrahim M. ; Shebl, Shebl Saeed</creator><creatorcontrib>Shamhout, Hend M. ; Ahmed, Amira Y. ; Fathy, Gamal A. ; Badraia, Ibrahim M. ; Shebl, Shebl Saeed</creatorcontrib><description>Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only commonly available curative treatment for people with thalassemia major (TM).This work aimed to study the impact of using low dose versus high dose anti thymocyte globulin (ATG (based conditioning regimen on the results of peripheral blood stem cell transplantation in children with βeta- TM. Methods: This comparative study was established on 40 patients with βeta-thalassemia major (Pesaro class II and/or III) who subjected to (HSCT)   from donor who is related. Our patients received the same myeloablative regimen. They were then categorized according to dose of ATG into two groups: group I (Busulfan/Cyclophosphamide/Low dose ATG-30 mg) and group II (Busulfan/Cyclophosphamide/High dose ATG-110 mg). Results: There was no association between both groups according to the clinical features, transplant related complications in both groups. There was a higher risk of mucositis and infections in high dose group. (P = 0.024 &amp; P = 0.046; respectively). Patients in low dose group achieved faster neutrophil engraftment with median value of (14 days). No difference was found in the incidence of post-transplant viral reactivation, graft versus host disease in both groups. Conclusions: Pesaro II, III thalassemia patients can safely receive hematopoietic stem cell transplantation (HSCT) with low dose ATG-30 mg regimen and attain the same result.</description><identifier>ISSN: 2456-8899</identifier><identifier>EISSN: 2456-8899</identifier><identifier>DOI: 10.9734/jammr/2022/v34i1231371</identifier><language>eng</language><ispartof>Journal of Advances in Medicine and Medical Research, 2022-04, p.33-41</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Shamhout, Hend M.</creatorcontrib><creatorcontrib>Ahmed, Amira Y.</creatorcontrib><creatorcontrib>Fathy, Gamal A.</creatorcontrib><creatorcontrib>Badraia, Ibrahim M.</creatorcontrib><creatorcontrib>Shebl, Shebl Saeed</creatorcontrib><title>Impact of using Low Dose versus High Dose Antithymocyte Globulin Based Conditioning Regimen on the Outcome of Peripheral Blood Stem Cell Transplantation in Children with βeta-thalassemia Major</title><title>Journal of Advances in Medicine and Medical Research</title><description>Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only commonly available curative treatment for people with thalassemia major (TM).This work aimed to study the impact of using low dose versus high dose anti thymocyte globulin (ATG (based conditioning regimen on the results of peripheral blood stem cell transplantation in children with βeta- TM. Methods: This comparative study was established on 40 patients with βeta-thalassemia major (Pesaro class II and/or III) who subjected to (HSCT)   from donor who is related. Our patients received the same myeloablative regimen. They were then categorized according to dose of ATG into two groups: group I (Busulfan/Cyclophosphamide/Low dose ATG-30 mg) and group II (Busulfan/Cyclophosphamide/High dose ATG-110 mg). Results: There was no association between both groups according to the clinical features, transplant related complications in both groups. There was a higher risk of mucositis and infections in high dose group. (P = 0.024 &amp; P = 0.046; respectively). Patients in low dose group achieved faster neutrophil engraftment with median value of (14 days). No difference was found in the incidence of post-transplant viral reactivation, graft versus host disease in both groups. Conclusions: Pesaro II, III thalassemia patients can safely receive hematopoietic stem cell transplantation (HSCT) with low dose ATG-30 mg regimen and attain the same result.</description><issn>2456-8899</issn><issn>2456-8899</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqdkEtOw0AMhkcIJCroFZAvUJoXbbOk4VEkEAi6j9zETaaaGUczk1a9FjfoBTgTCbDompUt6_f3S58QV2FwnU7jZLxBre04CqJovI0TGUZxGE_DEzGIkpvJaDZL09Oj_VwMnZOrIEmmSdxFB-LwpBssPPAaWidNBc-8gzt2BFuyrnWwkFX9e7g1Xvp6r7nYe4JHxatWSQNzdFRCxqaUXrLpGe9USU0G2ICvCV5bX7CmvuONrGxqsqhgrphL-PCkISOlYGnRuEah8dhzoENntVSl7UC7rhi-PsnjyNeo0DnSEuEFN2wvxdkalaPh37wQk4f7ZbYYFZads7TOGys12n0eBnnvLP9xlvfO8iNn8b8fvwFY_X5u</recordid><startdate>20220430</startdate><enddate>20220430</enddate><creator>Shamhout, Hend M.</creator><creator>Ahmed, Amira Y.</creator><creator>Fathy, Gamal A.</creator><creator>Badraia, Ibrahim M.</creator><creator>Shebl, Shebl Saeed</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20220430</creationdate><title>Impact of using Low Dose versus High Dose Antithymocyte Globulin Based Conditioning Regimen on the Outcome of Peripheral Blood Stem Cell Transplantation in Children with βeta-thalassemia Major</title><author>Shamhout, Hend M. ; Ahmed, Amira Y. ; Fathy, Gamal A. ; Badraia, Ibrahim M. ; Shebl, Shebl Saeed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_9734_jammr_2022_v34i12313713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Shamhout, Hend M.</creatorcontrib><creatorcontrib>Ahmed, Amira Y.</creatorcontrib><creatorcontrib>Fathy, Gamal A.</creatorcontrib><creatorcontrib>Badraia, Ibrahim M.</creatorcontrib><creatorcontrib>Shebl, Shebl Saeed</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of Advances in Medicine and Medical Research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shamhout, Hend M.</au><au>Ahmed, Amira Y.</au><au>Fathy, Gamal A.</au><au>Badraia, Ibrahim M.</au><au>Shebl, Shebl Saeed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of using Low Dose versus High Dose Antithymocyte Globulin Based Conditioning Regimen on the Outcome of Peripheral Blood Stem Cell Transplantation in Children with βeta-thalassemia Major</atitle><jtitle>Journal of Advances in Medicine and Medical Research</jtitle><date>2022-04-30</date><risdate>2022</risdate><spage>33</spage><epage>41</epage><pages>33-41</pages><issn>2456-8899</issn><eissn>2456-8899</eissn><abstract>Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only commonly available curative treatment for people with thalassemia major (TM).This work aimed to study the impact of using low dose versus high dose anti thymocyte globulin (ATG (based conditioning regimen on the results of peripheral blood stem cell transplantation in children with βeta- TM. Methods: This comparative study was established on 40 patients with βeta-thalassemia major (Pesaro class II and/or III) who subjected to (HSCT)   from donor who is related. Our patients received the same myeloablative regimen. They were then categorized according to dose of ATG into two groups: group I (Busulfan/Cyclophosphamide/Low dose ATG-30 mg) and group II (Busulfan/Cyclophosphamide/High dose ATG-110 mg). Results: There was no association between both groups according to the clinical features, transplant related complications in both groups. There was a higher risk of mucositis and infections in high dose group. (P = 0.024 &amp; P = 0.046; respectively). Patients in low dose group achieved faster neutrophil engraftment with median value of (14 days). No difference was found in the incidence of post-transplant viral reactivation, graft versus host disease in both groups. Conclusions: Pesaro II, III thalassemia patients can safely receive hematopoietic stem cell transplantation (HSCT) with low dose ATG-30 mg regimen and attain the same result.</abstract><doi>10.9734/jammr/2022/v34i1231371</doi></addata></record>
fulltext fulltext
identifier ISSN: 2456-8899
ispartof Journal of Advances in Medicine and Medical Research, 2022-04, p.33-41
issn 2456-8899
2456-8899
language eng
recordid cdi_crossref_primary_10_9734_jammr_2022_v34i1231371
source Alma/SFX Local Collection
title Impact of using Low Dose versus High Dose Antithymocyte Globulin Based Conditioning Regimen on the Outcome of Peripheral Blood Stem Cell Transplantation in Children with βeta-thalassemia Major
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T14%3A20%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20using%20Low%20Dose%20versus%20High%20Dose%20Antithymocyte%20Globulin%20Based%20Conditioning%20Regimen%20on%20the%20Outcome%20of%20Peripheral%20Blood%20Stem%20Cell%20Transplantation%20in%20Children%20with%20%CE%B2eta-thalassemia%20Major&rft.jtitle=Journal%20of%20Advances%20in%20Medicine%20and%20Medical%20Research&rft.au=Shamhout,%20Hend%20M.&rft.date=2022-04-30&rft.spage=33&rft.epage=41&rft.pages=33-41&rft.issn=2456-8899&rft.eissn=2456-8899&rft_id=info:doi/10.9734/jammr/2022/v34i1231371&rft_dat=%3Ccrossref%3E10_9734_jammr_2022_v34i1231371%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true